CATEGORIES

24.02.2017

24.02.2017 10:30

Je recommande vivement aux entrepreneurs suisses de collaborer avec la Chine

Au vu de l’importance que prend le marché chinois en termes de besoins, la levée de fonds réalisée en fin d'année dernière par Green Motion nous semble particulièrement intéressante en termes d’enseignements. Après avoir eu le plaisir de recevoir François Randin, le CEO de la scale-up lors du Startupticker Brunch Lausanne en janvier, notre rédaction a eu la chance de lui poser encore quelques questions.

23.02.2017

23.02.2017 09:00

Wachstumsfinanzierung in Höhe von 7,5 Millionen für Fintech-Startup bexio

Im vergangenen Jahr konnte bexio die Kundenbasis mehr als verdoppeln. Inzwischen arbeiten mehr als 8000 Unternehmen mit der Business Software des Fintech Startups. Eine Finanzierungsrunde mit dem Leadinvestor Swisscom Ventures sorgt nun für weiteren Schub.

21.02.2017

21.02.2017 09:15

Mundi Ventures Invests 1.5 Million CHF in Qumram

Qumram, a global RegTech firm, providing digital compliance and risk management solutions, has announced further investment of 1.5 million Swiss Francs, from the technology-focused venture capital firm, Mundi Ventures. Headquartered in Madrid, Mundi Ventures has operational presence in Barcelona, London and Seattle

13.02.2017

13.02.2017 07:54

Amicomed closes seed round

Launchpad Digital Health, a seed fund and accelerator for digital health based in San Francisco, announced it is leading seed round funding for Amicomed and four other companies. These companies have now begun its twelve-month in-house immersion program.

09.02.2017

09.02.2017 08:54

Glycemicon raises CHF3.25 million

Glycemicon AG is a Swiss biotechnology company developing so called nutraceuticals for managing prediabetes, diabetes and obesity. Nutraceuticals are products naturally occurring in food sources with extra health benefits. The company will use the funds to conduct its first clinical trials.

09.02.2017 08:30

Twenty Thirty AG closes first financing round

Twenty Thirty is a Zug based startup focusing on creating a decentralized world by creating innovation centres using of Blockchain technology. The startup announced the closing of its first round for the development products and services and infrastructure for innovation Centres.

07.02.2017

07.02.2017 13:23

Prexton Therapeutics raises CHF31 million

Geneva based Prexton Therapeutics develops novel therapeutic compounds for the treatment of Central Nervous System (CNS) conditions. The Series B funding will be used to finance two phase II studies of Prexton’s lead product. Prexton Therapeutics was founded 2012 as a spin-off from Merck Serono.

Show All

Events

02.03.2017 10:00 - 17:00

BlueLion - Tag der Offenen Tür BlueLion Zürich, Sihlquai 125, 8005 Zürich

Show All

Trainings

7th - 22nd March 2017

CTI Entrepreneurship - Business Growth - Module 4 EPFL Innovation Park - Lausanne

Top viewed

Show All

Video

Tweets

Principal

24.02.2017
Editorial

Thinking big

Partners

Contributors